Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GNG2 |
| Upstream (Parents) |
|---|
| (<<) CXCL12 → GNG2 |
| (<<) CD28 → GNG2 |
| (<<) FLI1 → GNG2 |
| (<<) FYN → GNG2 |
| Downstream (Children) |
|---|
| GNG2 → SYNE1 (>>) |
| GNG2 → RASSF2 (>>) |
| GNG2 → C14orf139 (>>) |
| GNG2 → PRR5L (>>) |
| GNG2 → C6orf204 (>>) |
| GNG2 → SYNPO2 (>>) |
| GNG2 → ERAP1 (>>) |
| GNG2 → CXCL12 (>>) |
| GNG2 → KIAA1324L (>>) |
| GNG2 → BHLHE22 (>>) |
| GNG2 → RORA (>>) |
| GNG2 → ATP8B2 (>>) |
| GNG2 → FYN (>>) |
| GNG2 → PKDCC (>>) |
| GNG2 → TACC1 (>>) |
| GNG2 → C13orf15 (>>) |
| GNG2 → DNMT3B (>>) |
